PAI Partners-backed SGD Pharma to acquire Alphial from Entangled Capital and Capital Dynamics.

PAI Partners-backed SGD Pharma, a glass manufacturing company, agreed to acquire Alphial, a packaging manufacturer focusing on glass vials and ampoules, from Entangled Capital, an Italy-based private equity firm, and Capital Dynamics, an asset management firm. Financial terms were not disclosed. "This acquisition represents a significant milestone in our growth strategy and will enable us to better serve our clients with an expanded portfolio of services and solutions," Olivier Rousseau, SGD Pharma CEO.